Consequently, plasma NfL holds promise as a biomarker for detecting neuronal injury in Alzheimer's disease because of its importance in prognosis and monitoring AD progression [94, 105]. This evidence concerns the gene NEFL and early-onset autosomal dominant Alzheimer disease.